Literature DB >> 12601754

Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.

Akihiro Tamori1, Shuhei Nishiguchi, Shoji Kubo, Masaru Enomoto, Noritoshi Koh, Tadashi Takeda, Susumu Shiomi, Kazuhiro Hirohashi, Hiroaki Kinoshita, Shuzo Otani.   

Abstract

DNA of free hepatitis B viruses (HBV) has been detected in the liver of patients infected with hepatitis C virus (HCV). It is unknown whether HBV DNA is integrated into such livers; if so, it may affect hepatocarcinogenesis. Hepatocellular carcinomas (HCCs) from 34 patients without HBV surface antigen (HBsAg) and with anti-HCV, and from 7 patients with HBsAg and without anti-HCV as controls, were examined, using the cassette-ligation-mediated polymerase chain reaction and primers based on HBV DNA sequence. In the controls, HBV DNA had been integrated into human DNA of all HCCs. On the basis of HBV DNA in tumor tissue, 23 of the 34 patients with anti-HCV had occult infection. Junctions between human DNA and HBV DNA were detected in 10 of the 34 patients without HBsAg and with anti-HCV. HBV DNA was integrated into chromosome 11q in 4 of the 10 HCCs with junctions. The DNA to either side of the human-viral junctions was sequenced. Clinically, the mean tumor size of these 10 HCCs was 39 mm; that of the 24 HCCs without integrated HBV was 25 mm. The surrounding tissue was cirrhotic in 2 of the 10 former HCCs and in 16 of the latter 24 HCCs. In conclusion, integrated HBV was detected in some patients with HCV infection; in these patients, the integrated DNA was associated with accelerated hepatocarcinogenesis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601754     DOI: 10.1002/jmv.10334

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Differences in cause-of-death patterns between the native Dutch and persons of Indonesian descent in the Netherlands.

Authors:  Lintje Ho; Vivian Bos; Anton E Kunst
Journal:  Am J Public Health       Date:  2007-07-31       Impact factor: 9.308

2.  Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Authors:  C M Martin; J A Welge; N J Shire; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2009-11-02       Impact factor: 3.728

3.  Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.

Authors:  Assem El-Sherif; Mohamed Abou-Shady; Hany Abou-Zeid; Ahmed Elwassief; Ashraf Elbahrawy; Yoshihide Ueda; Tsutomu Chiba; Abdel-Moneim Hosney
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

4.  Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Authors:  C M Martin; J A Welge; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2012-06-04       Impact factor: 3.728

5.  In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Authors:  Motswedi Anderson; Wonderful T Choga; Sikhulile Moyo; Trevor Graham Bell; Tshepiso Mbangiwa; Bonolo B Phinius; Lynette Bhebhe; Theresa K Sebunya; Joseph Makhema; Richard Marlink; Anna Kramvis; Max Essex; Rosemary M Musonda; Jason T Blackard; Simani Gaseitsiwe
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

Review 6.  HBV-Integration Studies in the Clinic: Role in the Natural History of Infection.

Authors:  Teresa Pollicino; Giuseppe Caminiti
Journal:  Viruses       Date:  2021-02-26       Impact factor: 5.048

Review 7.  Occult Hepatitis B Virus Infection: An Update.

Authors:  Carlo Saitta; Teresa Pollicino; Giovanni Raimondo
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

Review 8.  Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.

Authors:  Peiman Habibollahi; Saeid Safari; Nasser E Daryani; Seyed M Alavian
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

9.  Occult Hepatitis B (OBH) in Clinical Settings.

Authors:  Seyed Moayed Alavian; Seyed Mohammad Miri; F Blaine Hollinger; Seyed Mohammad Jazayeri
Journal:  Hepat Mon       Date:  2012-08-25       Impact factor: 0.660

10.  Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran.

Authors:  Zeinab Vakili Ghartavol; Seyed Moayed Alavian; Safieh Amini; Rouhollah Vahabpour; Golnaz Bahramali; Ehsan Mostafavi; Mohammad Reza Aghasadeghi
Journal:  Hepat Mon       Date:  2013-05-29       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.